Últimos ensayos

EudraCT Number: 2022-003922-27

Sponsor Protocol Number: PAM-UMCG-002

Start Date: 2024-02-08

Sponsor Name: University Medical Center Groningen (UMCG)

Full Title: Neo-adjuvant Pembrolizumab as alternative to radio(chemo)therapy in MMRd uterine cancer

Medical condition: Primary uterine cancer characterized with dMMR

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-004238-20

Sponsor Protocol Number: CC21000

Start Date: 2024-02-06

Sponsor Name: Vejle Hospital

Full Title: BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease

Medical condition: COPD

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10042613 - Surgical and medical procedures	10075530	Medical cannabis therapy	PT
	21.1	10038738 - Respiratory, thoracic and mediastinal disorders	10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2013-000356-18

Sponsor Protocol Number: 25051974

Start Date: 2023-12-21

Sponsor Name: Stichting Apotheek der Haarlemse Ziekenhuizen

Full Title: Effect of repeated intranasal cobalamin administration on cobalamin deficiency in elderly

Medical condition: Cobalamin (vitamin B12) deficiency

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: (No results available)

EudraCT Number: 2020-003146-36

Sponsor Protocol Number: RIAlta-1

Start Date: 2023-11-15

Sponsor Name: Vall d'Hebron Research Institute (VHIR)

Full Title: Safety of Rifampicin at High Dose for the Treatment of Adult Subjects with Complex Drug Susceptible Pulmonary and Extrapulmonary Tuberculosis

Medical condition: Pulmonary and extrapulmonary tuberculosis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-003804-15

Sponsor Protocol Number: SGMCBM

Start Date: 2023-11-09

Sponsor Name: Leiden University Medical Center

Full Title: A FEASIBILITY STUDY OF SGM-101, A FLUOROCHROME-LABELED ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY FOR THE INTRAOPERATIVE DETECTION OF COLORECTAL BRAIN METASTASES

Medical condition: Colorectal brain metastases

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052358	Colorectal cancer metastatic	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055093	Brain cancer metastatic	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001632-28

Sponsor Protocol Number: GENTLE

Start Date: 2023-10-24

Sponsor Name: Rijnstate

Full Title: Ghrelin in anterior circulation stroke and EVT

Medical condition: acute ischemic stroke

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-003318-35

Sponsor Protocol Number: VX22-264-101

Start Date: 2023-09-25

Sponsor Name: Vertex Pharmaceuticals Incorporated

Full Title: A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus

Medical condition: Type 1 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10027433 - Metabolism and nutrition disorders	10012601	Diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001287-10

Sponsor Protocol Number: NBK241/2/2022

Start Date: 2023-09-22

Sponsor Name: Gdański Uniwersytet Medyczny

Full Title: Treatment of acute ischemic stroke due to occlusion of a large vessel by mechanical thrombectomy in patients with unknown onset or not meeting the criteria for CT eligibility (ASPECTS

Medical condition: acute ischemic stroke caused by occlusion of a large vessel

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.1	10029205 - Nervous system disorders	10084836	Malignant ischemic stroke	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001021-74

Sponsor Protocol Number: HBI-3000-402

Start Date: 2023-08-30

Sponsor Name: HUYABIO International, LLC

Full Title: A Phase 2, Two-Stage, Serial Cohort Dose Escalation and Expansion Study of a Single Intravenous Infusion of HBI-3000 for the Conversion of Atrial Fibrillation (AF) of Recent Onset

Medical condition: Sustained atrial fibrillation (AF) of over 2 hours and

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10007541 - Cardiac disorders	10003658	Atrial fibrillation	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Completed)

Trial results: (No results available)

EudraCT Number: 2022-004078-53

Sponsor Protocol Number: 83403

Start Date: 2023-08-22

Sponsor Name: Academic Medical Center (AMC), department of Internal Medicine

Full Title: Specifying the anti-inflammatory effects of ziltivekimab with diverse imaging modalities and in-depth cellular phenotyping

Medical condition: - Plaque characteristics - Systemic inflammation

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

Últimos ensayos

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas